American Portfolios Advisors Intellia Therapeutics, Inc. Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 14,450 shares of NTLA stock, worth $323,391. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,450

Holding current value

$323,391

% of portfolio

0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$53.92 - $71.7 $779,144 - $1.04 Million	14,450 New	14,450 $809 Million
Q2 2022 Mar 20, 2023	BUY	$38.49 - $76.21 $26,250 - $51,975	682 Added 4.72%	15,132 $783 Million
Q1 2022 Mar 21, 2023	BUY	$58.27 - $118.99 $64,155 - $131,007	1,101 Added 7.62%	15,551 $1.13 Billion
Q4 2021 Mar 21, 2023	BUY	$100.76 - $138.36 $294,319 - $404,149	2,921 Added 20.21%	17,371 $2.05 Billion
Q3 2021 Mar 22, 2023	BUY	$132.37 - $176.78 $265,534 - $354,620	2,006 Added 13.88%	16,456 $2.21 Billion

Q2 2021 Mar 22, 2023	BUY	$60.88 - $161.91 $227,934 - $606,191	3,744 Added 25.91%	18,194 $2.95 Billion
Q1 2021 Mar 22, 2023	BUY	$46.59 - $83.68 $641,218 - $1.15 Million	13,763 Added 95.25%	28,213 $2.26 Billion
Q4 2020 Mar 22, 2023	BUY	$18.83 - $63.53 $166,701 - $562,431	8,853 Added 61.27%	23,303 $1.27 Billion
Q3 2020 Mar 22, 2023	SELL	$17.47 - $24.93 $9,014 - $12,863	-516 Reduced 3.57%	13,934 $277 Million
Q2 2020 Mar 24, 2023	BUY	$11.14 - $22.87 $52,669 - $108,129	4,728 Added 337.71%	6,128 $129 Million
Q1 2020 Mar 24, 2023	SELL	$9.44 - $15.58 $123,192 - $203,319	-13,050 Reduced 90.31%	1,400 $17.1 Million
Q4 2019 Mar 24, 2023	SELL	$10.43 - $17.67 $146,969 - $248,987	-14,091 Reduced 97.52%	359 $5.27 Million
Q3 2019 Mar 24, 2023	SELL	$13.07 - $18.51 $1,307 - $1,851	-100 Reduced 21.79%	359 $4.79 Million
Q2 2019 Mar 24, 2023	SELL	$13.88 - $18.41 $194,195 - $257,574	-13,991 Reduced 96.82%	459 $7.51 Million
Q4 2018 Mar 24, 2023	SELL	$11.39 - $27.13 $1,480 - $3,526	-130 Reduced 22.07%	459 $6.27 Million
Q3 2018 Mar 24, 2023	SELL	$25.78 - $32.6 $357,336 - $451,868	-13,861 Reduced 95.92%	589 $16.9 Million
Q2 2018 Mar 24, 2023	BUY	$20.02 - $30.79 $9,289 - $14,286	464 Added 371.2%	589 $16.1 Million
Q1 2018 Mar 24, 2023	SELL	$19.43 - $34.95 $278,334 - $500,658	-14,325 Reduced 99.13%	125 $2.64 Million

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

89.3M

Call Options Held

686K

Put Options Held

599K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.7B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Intellia Therapeutics, Inc. Transaction History